231 related articles for article (PubMed ID: 19172462)
1. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.
Morimoto S; Jo F; Maki K; Iwasaka T
Clin Exp Hypertens; 2009 Feb; 31(1):83-91. PubMed ID: 19172462
[TBL] [Abstract][Full Text] [Related]
2. Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers.
Okayama S; Imagawa K; Naya N; Iwama H; Somekawa S; Kawata H; Horii M; Nakajima T; Uemura S; Saito Y
Hypertens Res; 2006 Jul; 29(7):493-7. PubMed ID: 17044661
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
Harada K; Nomura M; Nishikado A; Uehara K; Nakaya Y; Ito S
Circ J; 2003 Feb; 67(2):139-45. PubMed ID: 12547996
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension.
Tanaka T; Tsutamoto T; Sakai H; Fujii M; Yamamoto T; Horie M
Hypertens Res; 2007 Aug; 30(8):691-7. PubMed ID: 17917316
[TBL] [Abstract][Full Text] [Related]
5. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
[TBL] [Abstract][Full Text] [Related]
6. Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
Ishimitsu T; Kameda T; Akashiba A; Takahashi T; Ohta S; Yoshii M; Minami J; Ono H; Numabe A; Matsuoka H
Hypertens Res; 2007 Jul; 30(7):621-6. PubMed ID: 17785930
[TBL] [Abstract][Full Text] [Related]
7. Effects of S(+)-efonidipine on the rabbit sinus node action potential and calcium channel subunits Ca(V)1.2, Ca(V)1.3 and Ca(V)3.1.
Tanaka H; Namekata I; Ogawa T; Tsuneoka Y; Komikado C; Takahara A; Iida-Tanaka N; Izumi-Nakaseko H; Tsuru H; Adachi-Akahane S
Eur J Pharmacol; 2010 Dec; 649(1-3):263-7. PubMed ID: 20858482
[TBL] [Abstract][Full Text] [Related]
8. Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels.
Furukawa T; Miura R; Honda M; Kamiya N; Mori Y; Takeshita S; Isshiki T; Nukada T
Br J Pharmacol; 2004 Dec; 143(8):1050-7. PubMed ID: 15545287
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension.
Oshima T; Ozono R; Yano Y; Higashi Y; Teragawa H; Miho N; Ishida T; Ishida M; Yoshizumi M; Kambe M
Hypertens Res; 2005 Nov; 28(11):889-94. PubMed ID: 16555577
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
[TBL] [Abstract][Full Text] [Related]
11. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
[TBL] [Abstract][Full Text] [Related]
12. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
Ogura C; Ono K; Miyamoto S; Ikai A; Mitani S; Sugimoto N; Tanaka S; Fujita M
Blood Press; 2012 Dec; 21(6):367-71. PubMed ID: 22747420
[TBL] [Abstract][Full Text] [Related]
13. Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms.
Lee TS; Kaku T; Takebayashi S; Uchino T; Miyamoto S; Hadama T; Perez-Reyes E; Ono K
Pharmacology; 2006; 78(1):11-20. PubMed ID: 16899990
[TBL] [Abstract][Full Text] [Related]
14. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
Tanaka H; Shigenobu K
Cardiovasc Drug Rev; 2002; 20(1):81-92. PubMed ID: 12070536
[TBL] [Abstract][Full Text] [Related]
15. Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients.
Nakano N; Ishimitsu T; Takahashi T; Inada H; Okamura A; Ohba S; Matsuoka H
Int Heart J; 2010 May; 51(3):188-92. PubMed ID: 20558909
[TBL] [Abstract][Full Text] [Related]
16. Effects of efonidipine, nicardipine and captopril on proteinuria in aged spontaneously hypertensive rats.
Shudo C; Masuda Y; Sugita H; Tamura T; Furukawa S; Hayashi K; Hirata H; Shikada K; Tanaka S; Tomita K
Arzneimittelforschung; 1996 Sep; 46(9):852-4. PubMed ID: 8876932
[TBL] [Abstract][Full Text] [Related]
17. [Effect of efonidipine hydrochloride on myocardial oxygen balance in anesthetized dogs].
Fujikura N; Yokoyama T; Masuda Y; Shikada K; Tanaka S
Nihon Yakurigaku Zasshi; 1996 Aug; 108(2):39-48. PubMed ID: 8827722
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
Sasaki H; Saiki A; Endo K; Ban N; Yamaguchi T; Kawana H; Nagayama D; Ohhira M; Oyama T; Miyashita Y; Shirai K
J Atheroscler Thromb; 2009 Oct; 16(5):568-75. PubMed ID: 19749494
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for efonidipine block of a voltage-gated Ca
Xu F; Xiong W; Huang Y; Shen J; Zhou D; Tang L
Biochem Biophys Res Commun; 2019 Jun; 513(3):631-634. PubMed ID: 30981510
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect.
Masumiya H; Shijuku T; Tanaka H; Shigenobu K
Eur J Pharmacol; 1998 May; 349(2-3):351-7. PubMed ID: 9671117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]